| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/30/2006 | CN1823740A Taxadol slow release nano-particle, its preparation method and application |
| 08/30/2006 | CN1823738A Powder ampoule agent for injection and its preparation method |
| 08/30/2006 | CN1823737A Porous drug matrices and methods of manufacture thereof |
| 08/30/2006 | CN1823736A Process to make a sustained release formulation |
| 08/30/2006 | CN1823734A Taxdol self assembled precusor liposome and its preparation method |
| 08/30/2006 | CN1823733A Self asembled precusor liposome containing camptothecin kind medicine and its preparation method |
| 08/30/2006 | CN1823732A Poly olefinic taxadol self assembled precusor liposome and its preparation method |
| 08/30/2006 | CN1823731A Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 08/30/2006 | CN1823729A Butyl benzene phthalein vein emulsion and its application |
| 08/30/2006 | CN1823727A Intestine target medicinal controlled release fiber and its preparation method |
| 08/30/2006 | CN1823725A Aerosol pharmaceutical compositions |
| 08/30/2006 | CN1823722A Medicinal tooth paste and its processing method |
| 08/30/2006 | CN1823626A Theobromine having carcinogenesis suppressing function |
| 08/30/2006 | CN1272354C Biodegradable copolymer and high molecular supermolecule composite containing same |
| 08/30/2006 | CN1272340C Oleanolic acid couple derivatives and their pharmaceutical use |
| 08/30/2006 | CN1272334C Quinuclidine derivs. as muscarinic M3 receptors ligand and their use |
| 08/30/2006 | CN1272332C Red clover total flavone high content extract, preparation and application in pharmaceutical combination thereof |
| 08/30/2006 | CN1272330C Compound 4-methoxy-7-methyl-3-oxo-1,3-dihydro isophenol furan-5-formaldehyde and its preparing method |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272326C Phenylpyridazine derivatives and drugs containing the same |
| 08/30/2006 | CN1272319C Process for making amlodipine maleate |
| 08/30/2006 | CN1272316C Benzamides and related inhibitors of factor Xa |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/30/2006 | CN1272042C Powder for sterilizing bacterium, climinating sore, removing purulence and promoting tissue regeneration as well as its preparing method |
| 08/30/2006 | CN1272038C Preparation of Chinese medicinal suppository for treating female chronic cervicitis |
| 08/30/2006 | CN1272027C Desmodium preparation for treating urinary calculus, infection and cholelithiasis cholecy stolithiasis and chole cystitis and its production method |
| 08/30/2006 | CN1272024C Use of dietary additives for preparing medicament for treating malignancies and viral infections and improving immunologic function |
| 08/30/2006 | CN1272019C Medical composite chitinamine gel |
| 08/30/2006 | CN1272018C Application of liquorice glycoside in preparing drugs for preventing and/or treating depression |
| 08/30/2006 | CN1272017C Method for preparing nano-microballons of Avermectins medicine and usage |
| 08/30/2006 | CN1272016C Use of ginkeo bilobwa extracts for preparing medicine for treating sarcopenia |
| 08/30/2006 | CN1272015C Adefovir dipivoxil and polyethylene glycol fused matter and its preparation method |
| 08/30/2006 | CN1272014C Enteric soluble preparation of Alun phosphorate and its preparing method |
| 08/30/2006 | CN1272013C Use of bisphosphonates in preparing drugs for treating diseases with abnormal bone formation in bone remodeling |
| 08/30/2006 | CN1272012C Dermatopathy therapeutic medicine compositions and its preparation method |
| 08/30/2006 | CN1272011C Phytosterol and/or plant steroid alkanol derivative |
| 08/30/2006 | CN1272010C Powdery respiratory tonic composition |
| 08/30/2006 | CN1272009C Freeze dried preparation of diammonium glycyrrhizinate and its preparation |
| 08/30/2006 | CN1272008C Application of diltiazem of hydrochloric acid in preparing antidote |
| 08/30/2006 | CN1272007C Compound formulation for preventing and treating broiler ascites syndrome |
| 08/30/2006 | CN1272006C Sildenafil citrate dripping pill |
| 08/30/2006 | CN1272005C Ligustrazine microcapsule and preparation method |
| 08/30/2006 | CN1272004C Use of Chinese medicinal palmatine hydrochloride in treatment of diabetes II |
| 08/30/2006 | CN1272003C Sophocarpidine gel preparation and its preparation |
| 08/30/2006 | CN1272002C Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 08/30/2006 | CN1272001C Aniracetam drop pills |
| 08/30/2006 | CN1272000C Troxerutin-coumarin dripping pill |
| 08/30/2006 | CN1271999C Use of extracts and preparations from iris plants and tectorigenin as organ selective medicament for treating urethra disease |
| 08/30/2006 | CN1271998C An anti-cataract medicine |
| 08/30/2006 | CN1271997C Oral disintegration tablets contg. p-acetaminophenol, and prepn. method therefor |
| 08/30/2006 | CN1271996C Medicinal powder injection for respiratory system and preparing method |
| 08/30/2006 | CN1271993C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 08/30/2006 | CN1271992C Cationic virosomes as transfer system for genetic material |
| 08/30/2006 | CN1271988C Cosmetics and medicinal preparation containing lightfast ultraviolet filter agent |
| 08/29/2006 | USRE39251 E.g., 7,11-Di(hydroxy)-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(methylthiazol-4-yl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione, preferably Form A; anticarcinogenic, -proliferative, -diabetic, -inflammatory agents; viricides; autoimmune diseases; psoriasis; agents; cardiovascular disorders |
| 08/29/2006 | US7098375 Animal and cell models for type II diabetes and their use |
| 08/29/2006 | US7098364 2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride; treating asthma and bronchitis |
| 08/29/2006 | US7098345 Transamination of orndansetron preparing by Mannich reaction and isolation of product |
| 08/29/2006 | US7098343 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor |
| 08/29/2006 | US7098340 Quinoline/chromene derivatives as androgen antagonist |
| 08/29/2006 | US7098338 2,3,4,4a-tetrahydro-1H-pyrazino(1,2-a) quinoxalin-5(6H)one derivatives |
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098336 FXR NR1H4 nuclear receptor binding compounds |
| 08/29/2006 | US7098335 Pyrazolopyrimidine compositions |
| 08/29/2006 | US7098334 Inhibitors of 5'-methylthioadenosine phosphorylase (MTAP) and 5'-methylthioadenosine nucleosidase (MTAN); treating cancer, malaria, bacterial infections; (1S)-1-(9-deazaadenin-9-yl)-1,4,5-trideoxy-1,4-imino-D-ribitol for example |
| 08/29/2006 | US7098333 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy |
| 08/29/2006 | US7098332 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098286 Covalently attaching to the surface a functionalized silicon compound include at least one activated silicon group and at least one derivatizable functional group |
| 08/29/2006 | US7098248 Beta-adrenergic blockade reversal of catabolism after severe burn |
| 08/29/2006 | US7098247 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives |
| 08/29/2006 | US7098246 Esterified hydroxytyrosol; 2-(3,4-dihydroxyphenyl)ethyl acetate for example |
| 08/29/2006 | US7098244 Antibacterial agent |
| 08/29/2006 | US7098243 Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2 |
| 08/29/2006 | US7098242 administering a compound of dihydroartemisinin dimerized with 1, 2 or 1, 3 or 1, 4 glycol under acidic conditions; antiprotzoal agents, anti-tumor agents |
| 08/29/2006 | US7098241 Thiophene hydroxamic acid derivatives |
| 08/29/2006 | US7098240 Compounds |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098238 2-pyrrolidone derivatives that are photolabile degradation products of bilirubin or biliverdin; used to detect vasospasm or vasoconstriction |
| 08/29/2006 | US7098237 administering type II sPLA2 inhibitor such as 2-[[3-(2-amino-2-oxoethyl)-2-ethyl-1-(1-naphthyl)methylene-1H-indene-4-yl]oxy]acetic acid |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098235 Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
| 08/29/2006 | US7098234 Indole derivatives, process for preparation of the same and use thereof |
| 08/29/2006 | US7098233 5-halo-tryptamine derivatives used as ligands on the 5-HT6 and/or 5-HT7 serotonin receptors |
| 08/29/2006 | US7098232 Treatment and prevention of gastrointestinal disease using antagonists of partial agonists of 5HT1a receptors |
| 08/29/2006 | US7098231 Viral polymerase inhibitors |
| 08/29/2006 | US7098230 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/29/2006 | US7098229 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2006 | US7098228 Indolyl derivatives |
| 08/29/2006 | US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 08/29/2006 | US7098224 Treating psoriasis, gastroesophageal reflux, Zollinger-Ellison Syndrome; antiulcer and antisecretory agents |
| 08/29/2006 | US7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 08/29/2006 | US7098222 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 08/29/2006 | US7098221 Immune response modifiers; cytokine biosynthesis; viral and neoplastic diseases; n-(4-(4-amino-6,7-dimethyl-1h-imidazo (4,5-c)pyridin-1-yl)butyl)benzamide |
| 08/29/2006 | US7098220 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/29/2006 | US7098219 Inhibitors of cellular efflux pumps of microbes |
| 08/29/2006 | US7098218 7,8,9, or 10-sulfamyl, (thio)phosphonyl, sulfonyl, or sulfonamido-naphth[2,1-f]isoquinolin-1,3-diones; drug screening; enzyme inhibitors; anticarcinogenic agents |
| 08/29/2006 | US7098217 3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands |
| 08/29/2006 | US7098216 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/29/2006 | US7098215 Nitrogenous compounds and antiviral drugs containing the same |